Patients who are prescribed antibiotics during immune checkpoint blockade therapy for solid tumors face a heightened risk for ...

Treating cancer with immunotherapies known as an immune checkpoint blockade (ICB) prior to surgery (so-called neoadjuvant immunotherapy) has been a rapidly growing area of research, but the scientific ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...

In a study published in the journal Biofunctional materials, researchers from the Wits Advanced Drug Delivery Platform (WADDP) Research Unit, Department of Pharmacy and Pharmacology, and the Division ...

Real-world experience of larotrectinib in children, adolescents and young adults with TRK fusion solid tumors in France. Feasibility of tumor-informed circulating tumor DNA (ctDNA) for molecular ...

Researchers have shown HIF1α as a key regulator that induces the cancer-killing capacity of T cells in hypoxic conditions. A team of researchers from the University of Alabama at Birmingham (AL, USA) ...